How to Stop Constipation on Mounjaro: What the Evidence Says

Why Mounjaro slows your gut, and what the trial data recorded

Tirzepatide activates both GIP and GLP-1 receptors, slowing the speed at which the stomach empties its contents. This is the same action that reduces appetite and flattens post-meal blood-sugar spikes, but it affects the whole digestive tract. Food moves more slowly through the bowel, more water is absorbed from it, and stools can become harder and less frequent. The NHS medicines page for tirzepatide lists constipation explicitly as a common side effect. SURMOUNT-1 data, published in the New England Journal of Medicine, recorded it as part of the gastrointestinal adverse-event profile that was dose-dependent, more likely to appear or worsen after a dose increase. Knowing this matters because it tells you when to expect it: typically in the first couple of weeks after starting or stepping up, then often settling. If it appears out of nowhere weeks into a stable dose, that conversation with your prescriber is worth having, and our guide to Mounjaro constipation covers the full picture of why this happens and what to do about it. You can read a fuller overview of the side-effect picture on our Mounjaro side effects guide.

What actually helps: fluid, fibre, movement and timing

The evidence base for managing GLP-1-related constipation is consistent across prescribing guidance and patient information. Start with water. Many people on Mounjaro eat and drink considerably less than before, helpful for weight loss, less helpful for bowel regularity. Aiming for six to eight glasses of plain water daily is a reasonable baseline, though personal needs vary. Soluble fibre (oats, lentils, flaxseed, ripe fruit) draws water into the stool and softens it; insoluble fibre (vegetable skins, wholegrains) adds bulk. Adding both gradually avoids the bloating that can come with a sudden dietary change. Gentle physical activity also stimulates gut motility; even a 20-minute walk after eating can help. Over-the-counter osmotic laxatives such as macrogol (Movicol or own-brand equivalents) are generally considered suitable alongside GLP-1 medicines, but check with your pharmacist or prescriber before using any laxative regularly, they can confirm it is appropriate for your full medical picture. The prevention strategies for Mounjaro-related constipation cover these steps in more detail, including how to build habits around your injection day. One practical note: Mounjaro arrives at your door in plain, unbranded packaging with DPD tracking, so you know exactly when to expect it, starting your hydration habits on injection day is a simple anchor point.

When constipation on Mounjaro needs medical attention

Most constipation on tirzepatide is uncomfortable rather than dangerous, but certain symptoms should prompt prompt medical attention. Seek urgent help if you have severe, persistent stomach pain that radiates to your back, with or without vomiting, this pattern can indicate acute pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines (issued January 2026) as an infrequent but serious side effect. Pancreatitis and constipation feel very different: pancreatitis pain is typically sudden, intense and does not ease with a bowel movement. Also contact your GP or prescriber if: you have not had a bowel movement for more than a week despite dietary measures; you notice blood in your stool or rectal bleeding; constipation is accompanied by significant bloating or vomiting; or symptoms began well into a stable dose period with no clear dietary trigger. Some people also find that physical discomfort from constipation affects their mood, and if you are wondering whether Mounjaro can help with anxiety or is making it worse, that is another useful topic to raise with your prescriber. If you experience any suspected side effect and are unsure whether it needs attention, you can report it directly through the MHRA Yellow Card scheme, patients can use it, not just clinicians. For more on the difference between typical and atypical bowel changes on tirzepatide, our page on whether Mounjaro causes constipation explains the mechanism in plain terms.

What to discuss with your prescriber

Constipation that does not respond to the standard measures (or that significantly affects your quality of life) is worth raising at your next clinical review rather than waiting it out in silence. A prescriber can consider whether your current dose needs more time at the current level before titrating, whether a specific laxative is suitable for you, or whether something unrelated to Mounjaro is contributing. At nume, every repeat order is reviewed by a GPhC-registered prescriber before dispatch; that review is the right moment to mention persistent side effects. If you have questions before your next scheduled review, our team is available seven days a week. You can find more detail about how we approach ongoing support on the about us page, or read about the full treatment journey on our Mounjaro overview. Our prescribers discuss suitability and side effects as part of every consultation, if constipation is a concern before you start, start your free consultation and raise it there.